← Back

$ Value

$0

Shares

32,547

Price

$0

Filed

May 22

Insider

Name

McKemey Adrian

Title

President, Drug Dev. Solutions

CIK

0002058990

Roles

Officer

Transaction Details

Transaction Date

2025-05-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

32,547

Footnotes

Each Certara, Inc. ("Company") performance stock unit ("PSU") was granted on May 20, 2025, pursuant to the terms of the 2025 Long-Term Incentive Plan for Company executives approved by the Compensation Committee of the Company's Board of Directors, under the Certara 2020 Incentive Plan (the "2020 Incentive Plan"). Each PSU represents a conditional right to receive one share of Company common stock. The reporting person will be entitled to receive a number of shares between 0% and 200% of the target amount reported based on the Company's performance against certain total shareholder return thresholds through the period ending on March 31, 2028. | Each restricted stock unit ("RSU") was granted on May 20, 2025, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. The RSUs will vest and settle in three equal installments on April 1, 2026, April 1, 2027, and April 1, 2028.

Filing Info

Accession No.

0001415889-25-014164

Form Type

4

Issuer CIK

0001827090

McKemey Adrian's History

Date Ticker Type Value
2026-04-01 CERT M $0
2026-04-01 CERT F $15K
2026-04-01 CERT M $0
2025-05-20 CERT A $0
2025-05-20 CERT A $0

Other Insiders at CERT (90d)

Insider Bought Sold Last
Pedersen Leif E
PRESIDENT, CHIEF COMMERCAL OFF
2026-04-01
Gallagher John E
Chief Financial Officer
2026-04-01
Aspbury Robert
PRESIDENT, PREDICTIVE TECH
2026-04-01
Anhalt Rona
Chief Human Resources Officer
2026-04-01
Corcoran Daniel
SVP and General Counsel
2026-04-01
McKemey Adrian
President, Drug Dev. Solutions
2026-04-01